1. Funding Opportunities
  2. Opportunity Detail

Funding Opportunity

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional)

Description:

The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval.

Closed:
Solicitation URL: https://www.grants.gov/web/grants/view-opportunity.html?oppId=330545
Post Date:
Close Date:
Last Updated Date:

Opportunity ID: 330545

Opportunity Number: PAR-21-092

Agency Name:
Eligible Applicants:

0 - State governments

1 - County governments

2 - City or township governments

4 - Special district goverments

5 - Independent school districts

6 - Public and State controlled institutions of higher education

7 - Native American tribal governments (Federally recognized)

8 - Public housing authorities/Indian housing authorities

11 - Native American tribal organizations (other than Federally recognized tribal governments)

12 - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education

13 - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education

20 - Private institutions of higher education

22 - For-profit organizations other than small businesses

23 - Small businesses

25 - Others